2024年Q3-2025年Q1美国药品渠道格局(英)

Circana, LLC | For public use1Copyright 2025 Circana, LLC (“Circana”). All rights reserved. Circana, the Circana logo, and the names of Circana products and services are trademarks of Circana. All other trademarks are the property of their respective owners.U.S. Drug Channel Landscape May 2025Q3 2024 – Q1 2025Circana, LLC | For public use2Executive SummaryIn this report, we follow up on trends identified in previous drug channel analyses and examine how these trends compare to the broader multioutlet and convenience channel landscape.In Q1 2025, drug channel salescontinue to lag the multioutlet market as consumers continue to shop other channels to save time and money.Consumers continue to seek wellness options that are more convenient and cost-efficient. The drug channel has an opportunity to drive more quick trips and dollars from the convenience channel and expand pharmacy operations.Drug channel dollar sales declined 5.5% in Q1 2025.The number of buyers purchasing in the drug channel declined less in Q1 2025 vs. Q4 2024 but is still declining as consumers continued to shop more at other channels.Average price inflation has increased in the health and beauty departments, which account for 66% of total dollar sales in the drug channel. The frequency of promotions remained high through 2024 and into 2025. Lift saw gains toward the end of 2024 and into 2025.In the drug channel, private label sales declined vs. YA across most departments, whereas in MULO+ w/ Convenience, private label has grown across all departments. Beauty department at drug declined 6% vs. YA, with the highest sales in skincare and cosmetics. Quick trips and special purpose trips are the primary trip types in drug. Consumers are shopping less in the drug channel, but the drug channel is important to consumers. Store closures continue, but consumers are loyal to their drug store and pharmacy. With about 40% of consumers enrolled in drug store loyalty programs, there’s an opportunity to further engage. Drug stores should also work to increase loyalty program enrollment. Consumers are becoming more conservative about spending with concern around inflation and the potential impact of tariffs on prices. While promo depth and breadth have remained relatively consistent, there’s been an uptick in sales lift based on promotions. Retailers can make promos meaningful without dramatically eroding margins. Retail pharmacy has an opportunity to expand into a more health care-oriented space to potentially bring in more consumers. Consumers appreciate the convenience of receiving vaccines at their local pharmacy, providing an opening for more services. There’s an opportunity to increase private label growth as consumers turn to store brands for lower prices. Products should reflect the pro-health nature of pharmacies. KEY TRENDSOPPORTUNITIES2Circana, LLC | For public useCircana, LLC | For public use33Circana, LLC | For public useSECTION 01Drug Channel Trends3Circana, LLC | For public useC

立即下载
综合
2025-09-29
44页
7.39M
收藏
分享

2024年Q3-2025年Q1美国药品渠道格局(英),点击即可下载。报告格式为PDF,大小7.39M,页数44页,欢迎下载。

本报告共44页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共44页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
图 3.6 甘肃省发债城投企业筹资活动现金净
综合
2025-09-29
来源:地方政府与城投企业债务风险研究报告-甘肃篇
查看原文
表 2.3 2023-2024 年甘肃省各地级市(州)政府性基金收入情况(单位:亿元)
综合
2025-09-29
来源:地方政府与城投企业债务风险研究报告-甘肃篇
查看原文
表 2.2 2024 年甘肃省各地级市(州)GDP 及增速情况
综合
2025-09-29
来源:地方政府与城投企业债务风险研究报告-甘肃篇
查看原文
表 2.1 甘肃省各地级市(州)产业分布情况
综合
2025-09-29
来源:地方政府与城投企业债务风险研究报告-甘肃篇
查看原文
表 1.4 2022-2024 年及 2025 年 1-6 月甘肃省主要财政数据
综合
2025-09-29
来源:地方政府与城投企业债务风险研究报告-甘肃篇
查看原文
表 1.2 2022-2024 年及 2025 年 1-6 月甘肃省主要经济数据
综合
2025-09-29
来源:地方政府与城投企业债务风险研究报告-甘肃篇
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起